Beijing Invites Trump for Summit with Xi Amid Ongoing Trade and Fentanyl Disputes

China has formally extended an invitation to U.S. President Donald Trump to visit Beijing for a high-level summit with President Xi Jinping, according to the Financial Times. However, the White House has yet to respond, as both nations remain divided on key issues, particularly trade disagreements and the flow of fentanyl into the United States.

The lack of meaningful progress in recent U.S.-China negotiations has lowered the chances of a major summit in Beijing. Instead, sources familiar with the matter suggest it is more likely that Trump and Xi will meet on the sidelines of the Asia-Pacific Economic Cooperation (APEC) forum in South Korea this October. Such a meeting would be lower profile compared to a formal state visit, signaling the ongoing difficulties in resolving disputes between the two largest economies.

Trade tensions between Washington and Beijing have been a central issue since Trump took office, with tariffs and market access continuing to dominate discussions. Another sticking point is the U.S. demand for stronger action from China to curb fentanyl exports, a synthetic opioid fueling America’s drug crisis. Despite multiple rounds of talks, little progress has been made, delaying the possibility of a breakthrough summit.

The Financial Times report underscores the fragile state of U.S.-China relations, where both countries aim to manage differences while maintaining a diplomatic channel. With no confirmation yet from the White House, the prospect of a high-level meeting in Beijing remains uncertain. Observers believe any eventual meeting, whether in China or at the APEC forum, will be closely watched as a critical moment for global trade and security.